The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins.
Open accessAbstract
In gene therapy to treat cancer, typically only a fraction of the tumor cells can be successfully transfected with a gene. However, in the case of brain tumor therapy with the thymidine kinase gene from herpes simplex virus (HSV-tk), not only the cells transfected with the gene but also neighboring others can be killed in the presence of ganciclovir. Such a "bystander" effect is reminiscent of our previous observation that the effect of certain therapeutic agents may be enhanced by their diffusion through gap junctional intercellular communication (GJIC). Herein, we present the evidence, from in vitro studies, that gap junctions could indeed be responsible for such a gene therapy bystander effect. We used HeLa cells for this purpose, since they show very little, if any, ability to communicate through gap junctions. When HeLa cells were transfected with HSV-tk gene and cocultured with nontransfected cells, only HSV-tk-transfected HeLa cells (tk+) were killed by ganciclovir. However, when HeLa cells transfected with a gene encoding for the gap junction protein, connexin 43 (Cx43), were used, not only tk+ cells, but also tk- cells were killed, presumably due to the transfer, via Cx43-mediated GJIC, of toxic ganciclovir molecules phosphorylated by HSV-tk to the tk- cells. Such bystander effect was not observed when tk+ and tk- cells were cocultured without direct cell-cell contact between those two types of cells. Thus, our results give strong evidence that the bystander effect seen in HSV-tk gene therapy may be due to Cx-mediated GJIC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Culver, K. W., Ram, Z., Wallbridge, S., Ishii, H., Oldfield, E. H., & Blaese, R. M. (1992) · Science · doi:10.1126/science.1317968 · Cited by 1,509
Connexin43: a protein from rat heart homologous to a gap junction protein from liver.
Beyer, E. C., Paul, D. L., & Goodenough, D. A. (1987) · The Journal of cell biology · doi:10.1083/jcb.105.6.2621 · Cited by 1,111
The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.
Freeman, S. M., Abboud, C. N., Whartenby, K. A., Packman, C. H., Koeplin, D. S., Moolten, F. L., & Abraham, G. N. (1993) · PubMed · Cited by 1,084
Elfgang, C., Eckert, R., Lichtenberg-Fraté, H., Butterweck, A., Traub, O., Klein, R. A., Hülser, D. F., & Willecke, K. (1995) · The Journal of cell biology · doi:10.1083/jcb.129.3.805 · Cited by 813
Self-citationSáez, J. C., Connor, J. A., Spray, D. C., & Bennett, M. V. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2708 · Cited by 595
Curability of Tumors Bearing Herpes Thymidine Kinase Genes Transfered by Retroviral Vectors
Moolten, F. L., & Wells, J. M. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.4.297 · Cited by 507
In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
Ram, Z., Culver, K. W., Walbridge, S., Blaese, R. M., & Oldfield, E. H. (1993) · PubMed · Cited by 433
Size Limit of Molecules Permeating the Junctional Membrane Channels
Simpson, I., Rose, B., & Loewenstein, W. R. (1977) · Science · doi:10.1126/science.831276 · Cited by 418
Li Bi, W., Parysek, L. M., Warnick, R., & Stambrook, P. J. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.6-725 · Cited by 416
Metabolic co-operation between biochemically marked mammalian cells in tissue culture
Subak-Sharpe, H., Bürk, R. R., & Pitts, J. D. (1969) · Journal of Cell Science · doi:10.1242/jcs.4.2.353 · Cited by 328
Gap junctional communication and carcinogenesis
Yamasaki, H. (1990) · Carcinogenesis · doi:10.1093/carcin/11.7.1051 · Cited by 311
Self-citationIntercellular calcium signaling via gap junctions in glioma cells.
Charles, A. C., Naus, C. C., Zhu, D., Kidder, G. M., Dirksen, E. R., & Sanderson, M. J. (1992) · The Journal of cell biology · doi:10.1083/jcb.118.1.195 · Cited by 308
Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid
Davidson, J. S., Baumgarten, I. M., & Harley, E. H. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90522-x · Cited by 301
Negative growth control of HeLa cells by connexin genes: connexin species specificity.
Mesnil, M., Krutovskikh, V. A., Piccoli, C., Elfgang, C., Traub, O., Willecke, K., & Yamasaki, H. (1995) · PubMed · Cited by 272
Self-citationTrosko, J. E., Madhukar, B. V., & Chang, C. C. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90606-4 · Cited by 139
Beyer, E. C. (1993) · PubMed · Cited by 139
Cited by
Westphal, M., Hilt, D. C., Bortey, E., Delavault, P., Olivares, R., Warnke, P. C., Whittle, I. R., Jääskeläinen, J., & Ram, Z. (2003) · Neuro-Oncology · doi:10.1093/neuonc/5.2.79 · Cited by 1,330
Radiation-induced bystander signalling in cancer therapy
Prise, K. M., & O'Sullivan, J. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2603 · Cited by 810
Gap-junction-mediated propagation and amplification of cell injury
Lin, J. H.-C., Weigel, H., Cotrina, M. L., Liu, S., Bueno, E., Hansen, A. J., Hansen, T. W., Goldman, S., & Nedergaard, M. (1998) · Nature Neuroscience · doi:10.1038/2210 · Cited by 480
Gap junctions and cancer: communicating for 50 years
Aasen, T., Mesnil, M., Naus, C. C., Lampe, P. D., & Laird, D. W. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.105 · Cited by 369
Self-citationIntercellular delivery of functional p53 by the herpesvirus protein VP22
Phelan, A., Elliott, G., & O'Hare, P. (1998) · Nature Biotechnology · doi:10.1038/nbt0598-440 · Cited by 283
Metadata
- Authors
- Mesnil, M., Piccoli, C., Tiraby, G., Willecke, K., & Yamasaki, H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-03-05
- Volume
- 93
- Issue
- 5
- Pages
- 1831-1835
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2003634190
- Cited by
- 411
- References
- 16
- FWCI
- 9.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.